DK0992509T3 - Nye makrolid-derivater - Google Patents

Nye makrolid-derivater

Info

Publication number
DK0992509T3
DK0992509T3 DK99307938T DK99307938T DK0992509T3 DK 0992509 T3 DK0992509 T3 DK 0992509T3 DK 99307938 T DK99307938 T DK 99307938T DK 99307938 T DK99307938 T DK 99307938T DK 0992509 T3 DK0992509 T3 DK 0992509T3
Authority
DK
Denmark
Prior art keywords
compounds
formula
macrolide derivatives
new macrolide
methods
Prior art date
Application number
DK99307938T
Other languages
English (en)
Inventor
Brian Scott Bronk
Hengmiao Cheng
Jason Kenneth Dutra
Michael Anthony Letavic
Robert John Rafka
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK0992509T3 publication Critical patent/DK0992509T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK99307938T 1998-10-09 1999-10-08 Nye makrolid-derivater DK0992509T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10383898P 1998-10-09 1998-10-09
EP99307938A EP0992509B1 (en) 1998-10-09 1999-10-08 Novel macrolide derivatives

Publications (1)

Publication Number Publication Date
DK0992509T3 true DK0992509T3 (da) 2004-12-20

Family

ID=22297279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99307938T DK0992509T3 (da) 1998-10-09 1999-10-08 Nye makrolid-derivater

Country Status (10)

Country Link
US (1) US6100240A (da)
EP (1) EP0992509B1 (da)
JP (1) JP3679656B2 (da)
AT (1) ATE277062T1 (da)
BR (1) BR9905089A (da)
CA (1) CA2286511C (da)
DE (1) DE69920362T2 (da)
DK (1) DK0992509T3 (da)
ES (1) ES2226294T3 (da)
PT (1) PT992509E (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
JP2001515865A (ja) * 1997-09-10 2001-09-25 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての９ａ−アザライド
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
KR20020002380A (ko) * 1999-01-27 2002-01-09 실버스타인 아써 에이. 케톨라이드 항생물질
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
AU3832100A (en) * 1999-05-24 2000-12-12 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
YU78702A (sh) * 2000-04-27 2005-11-28 Pfizer Products Inc. Upotreba azalid antibiotika za lečenje ili prevenciju bakterijske infekcije ili infekcije izazvane protozoama kod sisara
JP2005538927A (ja) * 2002-01-17 2005-12-22 コーザン バイオサイエンシス インコーポレイテッド アミドマクロライド
EP1482957A4 (en) 2002-02-15 2006-07-19 Merckle Gmbh ANTIBIOTIC CONJUGATES
US7579324B2 (en) 2002-02-15 2009-08-25 C-A-I-R Biosciences Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2003070173A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CN101423539B (zh) * 2008-12-09 2011-04-27 山东大学 4″,11-二氨基甲酸酯阿奇霉素衍生物、制备方法及其药物组合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN103965273B (zh) 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5641753A (en) * 1996-03-25 1997-06-24 Chris E. Platt 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined with sulfisoxazole
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
PT992509E (pt) 2004-12-31
EP0992509B1 (en) 2004-09-22
US6100240A (en) 2000-08-08
JP2000119294A (ja) 2000-04-25
EP0992509A2 (en) 2000-04-12
ES2226294T3 (es) 2005-03-16
ATE277062T1 (de) 2004-10-15
CA2286511A1 (en) 2000-04-09
EP0992509A3 (en) 2001-03-07
DE69920362D1 (de) 2004-10-28
JP3679656B2 (ja) 2005-08-03
BR9905089A (pt) 2000-08-08
DE69920362T2 (de) 2006-02-09
CA2286511C (en) 2003-07-08

Similar Documents

Publication Publication Date Title
DK0992509T3 (da) Nye makrolid-derivater
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
DE60144392D1 (de) Antivirale mittel
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
MA27040A1 (fr) Nucleosides substitues en 4'
ATE260263T1 (de) Heteroaromatische bizyklische verbindungen mit antikrebswirkung
EA200400432A1 (ru) Производные мочевины
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
TR200103395T2 (tr) 13-metil eritromisin türevleri.
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
FI944823A (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
AP9801377A0 (en) Tricyclic erythromycin derivatives.
AP9801235A0 (en) Erythromycin derivatives.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
DE69812059D1 (de) Beta,beta-disubstituierte Derivate von 9-Deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A